Bradley J. Bolzon Ph.D., Director, 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), sold 8,435 shares at $33.05 ($279K) on 2020-11-17, disclosed to the SEC on 2020-11-19.
Open-market sale of $279k BDTX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.05 | 489 | $16K | 5.8% |
| 2 | $33.05 | 3,705 | $122K | 43.9% |
| 3 | $33.05 | 3,705 | $122K | 43.9% |
| 4 | $33.09 | 63 | $2K | 0.7% |
| 5 | $33.09 | 473 | $16K | 5.6% |
| Total | $33.05 avg | 8,435 |
| $279K |
| 100% |
| Filing → |
| CRSP | SELL | 2021-06-30 | $14.1M | — | Filing → |
| CRSP | SELL | 2021-06-30 | $9.2M | — | Filing → |
| CRSP | SELL | 2021-06-15 | $2.3M | — | Filing → |